NCT02099786View on ClinicalTrials.gov

Randomized Trial Comparison of Ototoxicity Monitoring Programs

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

May 5, 2018

Study Completion Date

May 5, 2018

Conditions
Cisplatin OtotoxicityHearing Loss
Interventions
OTHER

COMP-VA

Hearing testing at each treatment interval by the comp-va audiologist

OTHER

Standard of care

Hearing testing done in the audiology clinic after oncology referral or patient self referral

Trial Locations (1)

97239

VA Portland Health Care System, Portland, OR, Portland

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02099786 - Randomized Trial Comparison of Ototoxicity Monitoring Programs | Biotech Hunter | Biotech Hunter